‘Gas Station Heroin’ Spurs Spike in Poison Control Calls, FDA Warns
Physician's Weekly
JUNE 17, 2025
Tianeptine is sold in a number of countries as a government-approved treatment for depression. The FDA sent a warning letter to the maker of a product called Tianna in 2018. Between 2018 and 2023, tianeptine-related calls to U.S. But the FDA has never approved it for any medical condition in the U.S. More information The U.S.
52 
Let's personalize your content